Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk

Seminars in Cancer Biology

Volumn 46, Issue , 2017, Pages 191-204

  Seidel, Derek V ^a   Azcárate Peril, M Andrea ^b   Chapkin, Robert S ^a   Turner, Nancy D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bioactives; Colon cancer; Metabolome; Microbiome

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

CANCER RESEARCH; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; COLON EPITHELIUM; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FRUIT; GENOMICS; HOST; HUMAN; INTESTINE EPITHELIUM; INTESTINE FLORA; LIFESTYLE; METABOLOME; METABOLOMICS; MICROBIAL METABOLISM; NONHUMAN; NUTRITION; PERSONALIZED MEDICINE; PROTEOMICS; REVIEW; CARCINOGENESIS; COLON TUMOR; DIET; DIET THERAPY; DRUG EFFECT; GENETICS; METABOLISM; RISK FACTOR;

CARCINOGENESIS; COLONIC NEOPLASMS; DIET; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLOME; PREBIOTICS; PROBIOTICS; RISK FACTORS;

EID: 85021931151     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2017.06.009     Document Type: Review

References (282)

1. Ahmed, R.L., Schmitz, K.H., Anderson, K.E., Rosamond, W.D., Folsom, A.R., The metabolic syndrome and risk of incident colorectal cancer. Cancer 107 (2006), 28–36.
2. Terzic, J., Grivennikov, S., Karin, E., Karin, M., Inflammation and colon cancer. Gastroenterology 138 (2010), 2101–2114 (e2105).
3. Datta, K., Suman, S., Kallakury, B.V., Fornace, A.J. Jr., Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater beta-catenin activation than gamma radiation in APC(Min/+) mice. PLoS One, 8, 2013, e59295.
4. Kim, J.H., Lim, Y.J., Kim, Y.H., Sung, I.K., Shim, S.G., Oh, S.O., Park, S.S., Yang, S., Son, H.J., Rhee, P.L., et al. Is metabolic syndrome a risk factor for colorectal adenoma?. Cancer Epidemiol. Biomark. Prev. 16 (2007), 1543–1546.
5. Kim, S.B., Bozeman, R.G., Kaisani, A., Kim, W., Zhang, L., Richardson, J.A., Wright, W.E., Shay, J.W., Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses. Oncogene 35 (2016), 3365–3375.
6. Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100 (2000), 57–70.
7. Block, K.I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A.R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin. Cancer Biol., 2015, S276–S304 (Elsevier).
8. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
9. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009), 1029–1033.
10. Feron, O., Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 92 (2009), 329–333.
11. Xie, J., Wu, H., Dai, C., Pan, Q., Ding, Z., Hu, D., Ji, B., Luo, Y., Hu, X., Beyond Warburg effect–dual metabolic nature of cancer cells. Sci. Rep., 4, 2014, 4927.
12. Hammoud, S.S., Cairns, B.R., Jones, D.A., Epigenetic regulation of colon cancer and intestinal stem cells. Curr. Opin. Cell Biol. 25 (2013), 177–183.
13. Pitot, H.C., The molecular biology of carcinogenesis. Cancer 72 (1993), 962–970.
14. Moody, C.S., Hassan, H.M., Mutagenicity of oxygen free radicals. Proc. Natl. Acad. Sci. U. S. A. 79 (1982), 2855–2859.
15. Yokota, J., Tumor progression and metastasis. Carcinogenesis 21 (2000), 497–503.
16. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
17. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
18. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
19. Kanauchi, O., Matsumoto, Y., Matsumura, M., Fukuoka, M., Bamba, T., The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. Curr. Pharm. Des. 11 (2005), 1047–1053.
20. Marchesi, J.R., Dutilh, B.E., Hall, N., Peters, W.H., Roelofs, R., Boleij, A., Tjalsma, H., Towards the human colorectal cancer microbiome. PLoS One, 6, 2011, e20447.
21. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
22. Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J., Furet, J.P., Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 6, 2011, e16393.
23. Tamboli, C.P., Neut, C., Desreumaux, P., Colombel, J.F., Dysbiosis in inflammatory bowel disease. Gut 53 (2004), 1–4.
24. Turner, N.D., Ritchie, L.E., Bresalier, R.S., Chapkin, R.S., The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr. Gastroenterol. Rep., 15, 2013, 346.
25. Irrazábal, T., Belcheva, A., Girardin, S.E., Martin, A., Philpott, D.J., The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell 54 (2014), 309–320.
26. Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic. Biol. Med. 49 (2010), 1603–1616.
27. Greer, J.B., O'Keefe, S.J., Microbial induction of immunity, inflammation, and cancer. Front. Physiol., 1, 2011, 168.
28. Karin, M., Lawrence, T., Nizet, V., Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124 (2006), 823–835.
29. Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
30. O'Keefe, S.J., Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 691–706.
31. Salonen, A., de Vos, W.M., Impact of diet on human intestinal microbiota and health. Annu. Rev. Food Sci. Technol. 5 (2014), 239–262.
32. Riboli, E., Norat, T., Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 78 (2003), 559S–569S.
33. Terry, P., Giovannucci, E., Michels, K.B., Bergkvist, L., Hansen, H., Holmberg, L., Wolk, A., Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J. Nat. Cancer Inst. 93 (2001), 525–533.
34. Trock, B., Lanza, E., Greenwald, P., Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Nat. Cancer Inst. 82 (1990), 650–661.
35. Kris-Etherton, P.M., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski, A.E., Hilpert, K.F., Griel, A.E., Etherton, T.D., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113 (2002), 71–88.
36. Papandreou, D., Noor, Z.T., Rashed, M., The role of soluble, insoluble fibers and their bioactive compounds in cancer: a mini review. Food Nutr. Sci., 6, 2015, 1.
37. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R., Garrido, I., Gomez-Cordoves, C., Andres-Lacueva, C., Bartolome, B., Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 1 (2010), 233–253.
38. Aura, A.M., Martin-Lopez, P., O'Leary, K.A., Williamson, G., Oksman-Caldentey, K.M., Poutanen, K., Santos-Buelga, C., In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 44 (2005), 133–142.
39. Aura, A.-M., Microbial metabolism of dietary phenolic compounds in the colon. Phytochem. Rev. 7 (2008), 407–429.
40. Clavel, T., Henderson, G., Alpert, C.A., Philippe, C., Rigottier-Gois, L., Dore, J., Blaut, M., Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl. Environ. Microbiol. 71 (2005), 6077–6085.
41. Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., Clevers, H., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007), 1003–1007.
42. Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009), 608–611.
43. Potten, C.S., Wilson, J.W., Booth, C., Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 15 (1997), 82–93.
44. Ruthig, D.J., Meckling-Gill, K.A., Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6. J. Nutr. 129 (1999), 1791–1798.
45. Clevers, H., The cancer stem cell: premises, promises and challenges. Nat. Med. 17 (2011), 313–319.
46. Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538 (2016), 260–264.
47. Huels, D.J., Sansom, O.J., Stem vs non-stem cell origin of colorectal cancer. Br. J. Cancer 113 (2015), 1–5.
48. Bienz, M., Clevers, H., Linking colorectal cancer to Wnt signaling. Cell 103 (2000), 311–320.
49. Suraweera, N., Robinson, J., Volikos, E., Guenther, T., Talbot, I., Tomlinson, I., Silver, A., Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int. J. Cancer 119 (2006), 1837–1842.
50. Polakis, P., Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol., 4, 2012, a008052.
51. Rycaj, K., Tang, D.G., Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res. 75 (2015), 4003–4011.
52. Davidson, L.A., Callaway, E.S., Kim, E., Weeks, B.R., Fan, Y.Y., Allred, C.D., Chapkin, R.S., Targeted deletion of p53 in Lgr5-expressing intestinal stem cells promotes colon tumorigenesis in a preclinical model of colitis-associated cancer. Cancer Res. 75 (2015), 5392–5397.
53. Chaffer, C.L., Weinberg, R.A., How does multistep tumorigenesis really proceed?. Cancer Discov. 5 (2015), 22–24.
54. Visvader, J.E., Clevers, H., Tissue-specific designs of stem cell hierarchies. Nat. Cell Biol. 18 (2016), 349–355.
55. Wu, S., Powers, S., Zhu, W., Hannun, Y.A., Substantial contribution of extrinsic risk factors to cancer development. Nature 529 (2016), 43–47.
56. Tomasetti, C., Vogelstein, B., Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347 (2015), 78–81.
57. Tetteh, P.W., Basak, O., Farin, H.F., Wiebrands, K., Kretzschmar, K., Begthel, H., van den Born, M., Korving, J., de Sauvage, F., van Es, J.H., et al. Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 18 (2016), 203–213.
58. Tetteh, P.W., Farin, H.F., Clevers, H., Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol. 25 (2015), 100–108.
59. Beyaz, S., Mana, M.D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.J., Bauer-Rowe, K.E., Xifaras, M.E., Akkad, A., Arias, E., et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531 (2016), 53–58.
60. DeClercq, V., McMurray, D.N., Chapkin, R.S., Obesity promotes colonic stem cell expansion during cancer initiation. Cancer Lett. 369 (2015), 336–343.
61. Igarashi, M., Guarente, L., mTORC1 and SIRT1 cooperate to foster expansion of gut adult stem cells during calorie restriction. Cell 166 (2016), 436–450.
62. Kim, E., Davidson, L.A., Zoh, R.S., Hensel, M.E., Salinas, M.L., Patil, B.S., Jayaprakasha, G.K., Callaway, E.S., Allred, C.D., Turner, N.D., et al. Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk. Cell Death Dis., 7, 2016, e2460.
63. Chang, W.C.L., Chapkin, R.S., Lupton, J.R., Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18 (1997), 721–730.
64. Ward, J.M., Uno, H., Kurata, Y., Weghorst, C.M., Jang, J.J., Cell proliferation not associated with carcinogenesis in rodents and humans. Environ. Health Perspect. 101 (1993), 125–135.
65. Reed, J.C., Mechanisms of apoptosis. Am. J. Pathol. 157 (2000), 1415–1430.
66. Fulda, S., Debatin, K.M., Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (2006), 4798–4811.
67. Saelens, X., Festjens, N., Vande Walle, L., van Gurp, M., van Loo, G., Vandenabeele, P., Toxic proteins released from mitochondria in cell death. Oncogene 23 (2004), 2861–2874.
68. Ichim, G., Tait, S.W., A fate worse than death: apoptosis as an oncogenic process. Nat. Rev. Cancer 16 (2016), 539–548.
69. Green, D.R., Kroemer, G., The pathophysiology of mitochondrial cell death. Science 305 (2004), 626–629.
70. Ng, Y., Barhoumi, R., Tjalkens, R.B., Fan, Y.Y., Kolar, S., Wang, N., Lupton, J.R., Chapkin, R.S., The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 26 (2005), 1914–1921.
71. Rodrigues, N.R., Rowan, A., Smith, M.E., Kerr, I.B., Bodmer, W.F., Gannon, J.V., Lane, D.P., p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 7555–7559.
72. Cho, Y., Turner, N.D., Davidson, L.A., Chapkin, R.S., Carroll, R.J., Lupton, J.R., A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas. Exp. Biol. Med. (Maywood, NJ) 237 (2012), 1387–1393.
73. Hong, M.Y., Chapkin, R.S., Davidson, L.A., Turner, N.D., Morris, J.S., Carroll, R.J., Lupton, J.R., Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr. Cancer 46 (2003), 44–51.
74. Wright, S.C., Zhong, J., Larrick, J.W., Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8 (1994), 654–660.
75. Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahuja, N., Issa, J.P., Markowitz, S., Willson, J.K., Hamilton, S.R., Kinzler, K.W., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6870–6875.
76. Cho, Y., Turner, N.D., Davidson, L.A., Chapkin, R.S., Carroll, R.J., Lupton, J.R., Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation. Exp. Biol. Med. (Maywood, NJ) 239 (2014), 302–310.
77. Glebov, O.K., Rodriguez, L.M., Nakahara, K., Jenkins, J., Cliatt, J., Humbyrd, C.J., DeNobile, J., Soballe, P., Simon, R., Wright, G., et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol. Biomark. Prev. 12 (2003), 755–762.
78. Barnicle, A., Seoighe, C., Golden, A., Greally, J.M., Egan, L.J., Differential DNA methylation patterns of homeobox genes in proximal and distal colon epithelial cells. Physiol. Genom. 48 (2016), 257–273.
79. Minoo, P., Zlobec, I., Peterson, M., Terracciano, L., Lugli, A., Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int. J. Oncol. 37 (2010), 707–718.
80. Yamauchi, M., Morikawa, T., Kuchiba, A., Imamura, Y., Qian, Z.R., Nishihara, R., Liao, X., Waldron, L., Hoshida, Y., Huttenhower, C., et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61 (2012), 847–854.
81. Watanabe, T., Kobunai, T., Toda, E., Yamamoto, Y., Kanazawa, T., Kazama, Y., Tanaka, J., Tanaka, T., Konishi, T., Okayama, Y., et al. Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res. 66 (2006), 9804–9808.
82. Hong, M.Y., Chang, W.C.L., Chapkin, R.S., Lupton, J.R., Relationship among colonocyte proliferation, differentiation, and apoptosis as a function of diet and carcinogen. Nutr. Cancer 28 (1997), 20–29.
83. Wiseman, H., Halliwell, B., Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:Pt 1 (1996), 17–29.
84. Meira, L.B., Bugni, J.M., Green, S.L., Lee, C.W., Pang, B., Borenshtein, D., Rickman, B.H., Rogers, A.B., Moroski-Erkul, C.A., McFaline, J.L., et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 118 (2008), 2516–2525.
85. Hahn, M.A., Hahn, T., Lee, D.H., Esworthy, R.S., Kim, B.W., Riggs, A.D., Chu, F.F., Pfeifer, G.P., Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68 (2008), 10280–10289.
86. Iliopoulos, D., Jaeger, S.A., Hirsch, H.A., Bulyk, M.L., Struhl, K., STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39 (2010), 493–506.
87. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A., Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30 (2009), 1073–1081.
88. Edwards, R.A., Witherspoon, M., Wang, K., Afrasiabi, K., Pham, T., Birnbaumer, L., Lipkin, S.M., Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res. 69 (2009), 6423–6429.
89. Vannucci, L., Stepankova, R., Kozakova, H., Fiserova, A., Rossmann, P., Tlaskalova-Hogenova, H., Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int. J. Oncol. 32 (2008), 609–617.
90. Sacksteder, M.R., Occurrence of spontaneous tumors in the germfree F344 rat. J. Natl. Cancer Inst. 57 (1976), 1371–1373.
91. Reddy, B.S., Weisburger, J.H., Narisawa, T., Wynder, E.L., Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n’-nitro-N-nitrosoguanidine. Cancer Res. 34 (1974), 2368–2372.
92. Reddy, B.S., Narisawa, T., Wright, P., Vukusich, D., Weisburger, J.H., Wynder, E.L., Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 35 (1975), 287–290.
93. Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4, 2009, e6026.
94. Grivennikov, S.I., Wang, K., Mucida, D., Stewart, C.A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.Y., Osterreicher, C.H., Hung, K.E., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491 (2012), 254–258.
95. Klimesova, K., Kverka, M., Zakostelska, Z., Hudcovic, T., Hrncir, T., Stepankova, R., Rossmann, P., Ridl, J., Kostovcik, M., Mrazek, J., et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm. Bowel Dis. 19 (2013), 1266–1277.
96. Garaude, J., Kent, A., van Rooijen, N., Blander, J.M., Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci. Transl. Med., 4, 2012, 120ra116.
97. Pradere, J.P., Dapito, D.H., Schwabe, R.F., The Yin and Yang of Toll-like receptors in cancer. Oncogene 33 (2014), 3485–3495.
98. Ott, S., Musfeldt, M., Wenderoth, D., Hampe, J., Brant, O., Fölsch, U., Timmis, K., Schreiber, S., Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53 (2004), 685–693.
99. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55 (2006), 205–211.
100. Sepehri, S., Kotlowski, R., Bernstein, C.N., Krause, D.O., Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 13 (2007), 675–683.
101. Ritchie, L.E., Sturino, J.M., Carroll, R.J., Rooney, L.W., Azcarate-Peril, M.A., Turner, N.D., Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis. FEMS Microbiol. Ecol., 91, 2015, fiv008.
102. Ritchie, L.E., Taddeo, S.S., Weeks, B.R., Lima, F., Bloomfield, S.A., Azcarate-Peril, M.A., Zwart, S.R., Smith, S.M., Turner, N.D., Space environmental factor impacts upon murine colon microbiota and mucosal homeostasis. PLoS One, 10, 2015, e0125792.
103. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., Zhao, L., Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6 (2012), 320–329.
104. Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z., et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66 (2013), 462–470.
105. Mira-Pascual, L., Cabrera-Rubio, R., Ocon, S., Costales, P., Parra, A., Suarez, A., Moris, F., Rodrigo, L., Mira, A., Collado, M.C., Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J. Gastroenterol. 50 (2015), 167–179.
106. Chen, W., Liu, F., Ling, Z., Tong, X., Xiang, C., Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One, 7, 2012, e39743.
107. Weir, T.L., Manter, D.K., Sheflin, A.M., Barnett, B.A., Heuberger, A.L., Ryan, E.P., Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One, 8, 2013, e70803.
108. Sanchez-Espiridion, B., White, L., Mishra, L., Raju, G.S., Kopetz, S., Gu, J., Ye, Y., Wu, X., Liang, D., Abstract 8: global and targeted metabolomic profiling of colorectal cancer progression. Cancer Res., 76, 2016, 8.
109. Brown, D.G., Rao, S., Weir, T.L., O'Malia, J., Bazan, M., Brown, R.J., Ryan, E.P., Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab., 4, 2016, 11.
110. Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., Gorvel, J.P., Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat. Rev. Microbiol. 15 (2017), 109–128.
111. Vizcaino, M.I., Crawford, J.M., The colibactin warhead crosslinks DNA. Nat. Chem. 7 (2015), 411–417.
112. Wu, S., Powell, J., Mathioudakis, N., Kane, S., Fernandez, E., Sears, C.L., Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway. Infect. Immun. 72 (2004), 5832–5839.
113. Wu, S., Shin, J., Zhang, G., Cohen, M., Franco, A., Sears, C.L., The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect. Immun. 74 (2006), 5382–5390.
114. Goodwin, A.C., Destefano Shields, C.E., Wu, S., Huso, D.L., Wu, X., Murray-Stewart, T.R., Hacker-Prietz, A., Rabizadeh, S., Woster, P.M., Sears, C.L., Casero, R.A. Jr., Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 15354–15359.
115. Boleij, A., Hechenbleikner, E.M., Goodwin, A.C., Badani, R., Stein, E.M., Lazarev, M.G., Ellis, B., Carroll, K.C., Albesiano, E., Wick, E.C., et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60 (2015), 208–215.
116. Lu, R., Wu, S., Zhang, Y.G., Xia, Y., Zhou, Z., Kato, I., Dong, H., Bissonnette, M., Sun, J., Salmonella protein AvrA activates the STAT3 signaling pathway in colon cancer. Neoplasia 18 (2016), 307–316.
117. Corvinus, F.M., Orth, C., Moriggl, R., Tsareva, S.A., Wagner, S., Pfitzner, E.B., Baus, D., Kaufman, R., Huber, L.A., Zatloukal, K., et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7 (2005), 545–555.
118. Lin, L., Liu, A., Peng, Z., Lin, H.J., Li, P.K., Li, C., Lin, J., STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res. 71 (2011), 7226–7237.
119. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., Karin, M., IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15 (2009), 103–113.
120. Bromberg, J., Wang, T.C., Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15 (2009), 79–80.
121. Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A., Bringer, M.A., Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab. Invest. 95 (2015), 296–307.
122. Wang, X., Huycke, M.M., Colorectal cancer: role of commensal bacteria and bystander effects. Gut Microbes 6 (2015), 370–376.
123. Anson, N.M., Selinheimo, E., Havenaar, R., Aura, A.M., Mattila, I., Lehtinen, P., Bast, A., Poutanen, K., Haenen, G.R., Bioprocessing of wheat bran improves in vitro bioaccessibility and colonic metabolism of phenolic compounds. J. Agric. Food Chem. 57 (2009), 6148–6155.
124. Hemery, Y.M., Anson, N.M., Havenaar, R., Haenen, G.R., Noort, M.W., Rouau, X., Dry-fractionation of wheat bran increases the bioaccessibility of phenolic acids in breads made from processed bran fractions. Food Res. Int. 43 (2010), 1429–1438.
125. Maciorowski, K.G., Turner, N.D., Lupton, J.R., Chapkin, R.S., Shermer, C.L., Ha, S.D., Ricke, S.C., Diet and carcinogen alter the fecal microbial populations of rats. J. Nutr. 127 (1997), 449–457.
126. Taguri, T., Tanaka, T., Kouno, I., Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol. Pharm. Bull. 27 (2004), 1965–1969.
127. Sójka, M., Kołodziejczyk, K., Milala, J., Abadias, M., Viñas, I., Guyot, S., Baron, A., Composition and properties of the polyphenolic extracts obtained from industrial plum pomaces. J. Funct. Foods 12 (2015), 168–178.
128. O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J.M., Kinross, J., Wahl, E., Ruder, E., Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun., 2015, 6.
129. Zhang, Z., Geng, J., Tang, X., Fan, H., Xu, J., Wen, X., Ma, Z.S., Shi, P., Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota. ISME J. 8 (2014), 881–893.
130. Consortium HMP, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
131. Clifford, M., Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 70 (2004), 1103–1114.
132. Williamson, G., Clifford, M.N., Colonic metabolites of berry polyphenols: the missing link to biological activity?. Br. J. Nutr. 104:Suppl. 3 (2010), S48–66.
133. Zhang, L.S., Davies, S.S., Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med., 8, 2016, 46.
134. Cheng, Y., Jin, U.H., Allred, C.D., Jayaraman, A., Chapkin, R.S., Safe, S., Aryl hydrocarbon receptor activity of tryptophan metabolites in young adult mouse colonocytes. Drug Metab. Dispos. 43 (2015), 1536–1543.
135. Louis, P., Hold, G.L., Flint, H.J., The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12 (2014), 661–672.
136. Turner, N.D., Lupton, J.R., Dietary fiber. Adv. Nutr. 2 (2011), 151–152.
137. Macfarlane, G.T., Macfarlane, S., Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. Suppl. 222 (1997), 3–9.
138. Lupton, J.R., Kurtz, P.P., Relationship of colonic luminal short-chain fatty acids and pH to in vivo cell proliferation in rats. J. Nutr. 123 (1993), 1522–1530.
139. Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., Macfarlane, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987), 1221–1227.
140. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27 (2008), 104–119.
141. Lupton, J.R., Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr. 134 (2004), 479–482.
142. Lupton, J.R., Turner, N.D., Potential protective mechanisms of wheat bran fiber. Am. J. Med. 106 (1999), 24S–27S.
143. Gazzaniga, J.M., Lupton, J.R., Dilution effect of dietary fiber sources: an in vivo study in the rat. Nutr. Res. 7 (1987), 1261–1268.
144. Lewis, S.J., Heaton, K.W., Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41 (1997), 245–251.
145. Zoran, D.L., Turner, N.D., Taddeo, S.S., Chapkin, R.S., Lupton, J.R., Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J. Nutr. 127 (1997), 2217–2225.
146. Tudela, C.V., Boudry, C., Stumpff, F., Aschenbach, J.R., Vahjen, W., Zentek, J., Pieper, R., Down-regulation of monocarboxylate transporter 1 (MCT1) gene expression in the colon of piglets is linked to bacterial protein fermentation and pro-inflammatory cytokine-mediated signalling. Br. J. Nutr. 113 (2015), 610–617.
147. Liu, X., Blouin, J.-M., Santacruz, A., Lan, A., Andriamihaja, M., Wilkanowicz, S., Benetti, P.-H., Tomé D., Sanz, Y., Blachier, F., High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection. Am. J. Physiol. Gastrointest. Liver Physiol. 307 (2014), G459–G470.
148. Donohoe, D.R., Curry, K.P., Bultman, S.J., Microbial oncotarget: bacterial-produced butyrate, chemoprevention and Warburg effect. Oncotarget 4 (2013), 182–183.
149. Vital, M., Howe, A.C., Tiedje, J.M., Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio, 5, 2014, e00889.
150. Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., Bultman, S.J., The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48 (2012), 612–626.
151. Zimmerman, M.A., Singh, N., Martin, P.M., Thangaraju, M., Ganapathy, V., Waller, J.L., Shi, H., Robertson, K.D., Munn, D.H., Liu, K., Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am. J. Physiol. 302 (2012), G1405–G1415.
152. Ganapathy, V., Gurav, A., Singh, N., The Butyrate Transporter SLC5A8 is a Tumor Suppressor in Colon Linked to Dietary Fiber Content. 2015, AACR.
153. Gurav, A., Sivaprakasam, S., Bhutia, Y.D., Boettger, T., Singh, N., Ganapathy, V., Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions. Biochem. J. 469 (2015), 267–278.
154. Gurav, A., Singh, N., Ganapathy, V., A critical role for Slc5a8 in the suppression of colonic inflammation by commensal bacteria-derived metabolites (MUC9P. 821). J. Immunol., 192, 2014 199.198–199.198.
155. Chapkin, R.S., Fan, Y., Lupton, J.R., Effect of diet on colonic-programmed cell death: molecular mechanism of action. Toxicol. Lett. 112:113 (2000), 411–414.
156. Fan, Y.Y., Zhang, J., Barhoumi, R., Burghardt, R.C., Turner, N.D., Lupton, J.R., Chapkin, R.S., Antagonism of CD95 signaling blocks butyrate induction of apoptosis in young adult mouse colonic cells. Am. J. Physiol. 277 (1999), C310–319.
157. Kim, M., Qie, Y., Park, J., Kim, C.H., Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20 (2016), 202–214.
158. Furusawa, Y., Obata, Y., Hase, K., Commensal microbiota regulates T cell fate decision in the gut. Semin. Immunopathol., 2015, 17–25 (Springer).
159. Crim, K.C., Sanders, L.M., Hong, M.Y., Taddeo, S.S., Turner, N.D., Chapkin, R.S., Lupton, J.R., Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis 29 (2008), 1415–1420.
160. Belcheva, A., Irrazabal, T., Martin, A., Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?. Bioessays 37 (2015), 403–412.
161. Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E.H., Copeland, J.K., Kumar, S., Green, B., et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158 (2014), 288–299.
162. Triff, K., Kim, E., Chapkin, R.S., Chemoprotective epigenetic mechanisms in a colorectal cancer model: modulation by n-3 PUFA in combination with fermentable fiber. Curr. Pharmacol. Rep. 1 (2015), 11–20.
163. Chapkin, R.S., DeClercq, V., Kim, E., Fuentes, N.R., Fan, Y.Y., Mechanisms by which pleiotropic amphiphilic n-3 PUFA reduce colon cancer risk. Curr. Colorectal Cancer Rep. 10 (2014), 442–452.
164. Kolar, S.S., Barhoumi, R., Lupton, J.R., Chapkin, R.S., Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation. Cancer Res. 67 (2007), 5561–5568.
165. Chapkin, R.S., Davidson, L.A., Ly, L., Weeks, B.R., Lupton, J.R., McMurray, D.N., Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J. Nutr. 137 (2007), 200S–204S.
166. Davidson, L.A., Nguyen, D.V., Hokanson, R.M., Callaway, E.S., Isett, R.B., Turner, N.D., Dougherty, E.R., Wang, N., Lupton, J.R., Carroll, R.J., Chapkin, R.S., Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 64 (2004), 6797–6804.
167. Hong, M.Y., Chapkin, R.S., Barhoumi, R., Burghardt, R.C., Turner, N.D., Henderson, C.E., Sanders, L.M., Fan, Y.Y., Davidson, L.A., Murphy, M.E., et al. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 23 (2002), 1919–1925.
168. Chapkin, R.S., Hong, M.Y., Fan, Y.Y., Davidson, L.A., Sanders, L.M., Henderson, C.E., Barhoumi, R., Burghardt, R.C., Turner, N.D., Lupton, J.R., Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 37 (2002), 193–199.
169. Hong, M.Y., Lupton, J.R., Morris, J.S., Wang, N., Carroll, R.J., Davidson, L.A., Elder, R.H., Chapkin, R.S., Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol. Biomark. Prev. 9 (2000), 819–826.
170. Hong, M.Y., Turner, N.D., Murphy, M.E., Carroll, R.J., Chapkin, R.S., Lupton, J.R., In vivo regulation of colonic cell proliferation, differentiation, apoptosis, and P27Kip1 by dietary fish oil and butyrate in rats. Cancer Prev. Res. (Philadelphia, Pa) 8 (2015), 1076–1083.
171. Vanamala, J., Glagolenko, A., Yang, P., Carroll, R., Murphy, M., Newman, R., Ford, J., Braby, L., Chapkin, R., Turner, N., Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARδ/PGE2 and elevation of PGE3. Carcinogenesis 29 (2008), 790–796.
172. Chang, W.C.L., Chapkin, R.S., Lupton, J.R., Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J. Nutr. 128 (1998), 491–497.
173. Kim, E., Davidson, L.A., Patil, B.S., Jayaprakasha, G.K., Callaway, E.S., Turner, N.D., Chapkin, R.S., Effects of chemoprotective diets on crypt adult stem cells: the cells of origin of colon cancer (819.1). FASEB J., 2014, 28.
174. Orlich, M.J., Singh, P.N., Sabate, J., Fan, J., Sveen, L., Bennett, H., Knutsen, S.F., Beeson, W.L., Jaceldo-Siegl, K., Butler, T.L., et al. Vegetarian dietary patterns and the risk of colorectal cancers. JAMA Intern. Med. 175 (2015), 767–776.
175. Liu, R.H., Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 78 (2003), 517S–520S.
176. Tsao, R., Yang, R., Young, J.C., Zhu, H., Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC). J. Agric. Food Chem. 51 (2003), 6347–6353.
177. Vanamala, J., Cobb, G., Turner, N.D., Lupton, J.R., Yoo, K.S., Pike, L.M., Patil, B.S., Bioactive compounds of grapefruit (Citrus paradisi Cv. Rio Red) respond differently to postharvest irradiation, storage, and freeze drying. J. Agric. Food Chem. 53 (2005), 3980–3985.
178. Dinkova-Kostova, A.T., Phytochemicals as protectors against ultraviolet radiation: versatility of effects and mechanisms. Planta Med. 74 (2008), 1548–1559.
179. Alothman, M., Bhat, R., Karim, A., Effects of radiation processing on phytochemicals and antioxidants in plant produce. Trends Food Sci. Technol. 20 (2009), 201–212.
180. Cowan, M.M., Plant products as antimicrobial agents. Clin. Microbiol. Rev., 12, 1999, 564.
181. Holt, E.M., Steffen, L.M., Moran, A., Basu, S., Steinberger, J., Ross, J.A., Hong, C.P., Sinaiko, A.R., Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J. Am. Dietetic Assoc. 109 (2009), 414–421.
182. Siriwardhana, N., Kalupahana, N.S., Cekanova, M., LeMieux, M., Greer, B., Moustaid-Moussa, N., Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 24 (2013), 613–623.
183. Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols. J. Nutr. 130 (2000), 2073S–2085S.
184. Dykes, Phenolic compounds in cereal grains and their health benefits. Cereal Foods World 52 (2007), 105–111.
185. Vanamala, J., Leonardi, T., Patil, B.S., Taddeo, S.S., Murphy, M.E., Pike, L.M., Chapkin, R.S., Lupton, J.R., Turner, N.D., Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis 27 (2006), 1257–1265.
186. Leonardi, T., Vanamala, J., Taddeo, S.S., Davidson, L.A., Murphy, M.E., Patil, B.S., Wang, N., Carroll, R.J., Chapkin, R.S., Lupton, J.R., Turner, N.D., Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp. Biol. Med. (Maywood, NJ) 235 (2010), 710–717.
187. Yang, C.S., Landau, J.M., Huang, M.T., Newmark, H.L., Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21 (2001), 381–406.
188. Lea, M.A., Ibeh, C., desBordes, C., Vizzotto, M., Cisneros-Zevallos, L., Byrne, D.H., Okie, W.R., Moyer, M.P., Inhibition of growth and induction of differentiation of colon cancer cells by peach and plum phenolic compounds. Anticancer Res. 28 (2008), 2067–2076.
189. Lea, M.A., Ibeh, C., Han, L., Desbordes, C., Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells. Anticancer Res. 30 (2010), 311–318.
190. Miene, C., Weise, A., Glei, M., Impact of polyphenol metabolites produced by colonic microbiota on expression of COX-2 and GSTT2 in human colon cells (LT97). Nutr. Cancer 63 (2011), 653–662.
191. Link, A., Balaguer, F., Goel, A., Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem. Pharmacol. 80 (2010), 1771–1792.
192. Banerjee, N., Kim, H., Talcott, S.T., Turner, N.D., Byrne, D.H., Mertens-Talcott, S.U., Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis. Nutr. Res. 36 (2016), 1105–1113.
193. Shankar, E., Kanwal, R., Candamo, M., Gupta, S., Dietary phytochemicals as epigenetic modifiers in cancer: promise and challenges. Semin. Cancer Biol., 2016, 82–99 (Elsevier).
194. Rechner, A.R., Smith, M.A., Kuhnle, G., Gibson, G.R., Debnam, E.S., Srai, S.K., Moore, K.P., Rice-Evans, C.A., Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med. 36 (2004), 212–225.
195. Déprez, S., Brezillon, C., Rabot, S., Philippe, C., Mila, I., Lapierre, C., Scalbert, A., Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 130 (2000), 2733–2738.
196. Cardona, F., Andres-Lacueva, C., Tulipani, S., Tinahones, F.J., Queipo-Ortuno, M.I., Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 24 (2013), 1415–1422.
197. Duenas, M., Munoz-Gonzalez, I., Cueva, C., Jimenez-Giron, A., Sanchez-Patan, F., Santos-Buelga, C., Moreno-Arribas, M.V., Bartolome, B., A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int., 2015, 2015, 850902.
198. Etxeberria, U., Fernandez-Quintela, A., Milagro, F.I., Aguirre, L., Martinez, J.A., Portillo, M.P., Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J. Agric. Food Chem. 61 (2013), 9517–9533.
199. Guo, L.D., Chen, X.J., Hu, Y.H., Yu, Z.J., Wang, D., Liu, J.Z., Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother. Res. 27 (2013), 422–430.
200. Stacewicz-Sapuntzakis, M., Bowen, P.E., Hussain, E.A., Damayanti-Wood, B.I., Farnsworth, N.R., Chemical composition and potential health effects of prunes: a functional food?. Crit. Rev. Food Sci. Nutr. 41 (2001), 251–286.
201. Fang, N., Yu, S., Prior, R.L., LC/MS/MS characterization of phenolic constituents in dried plums. J. Agric. Food Chem. 50 (2002), 3579–3585.
202. Piefer, L.A., Weeks, B., Carroll, R., Byrne, D., Ambrus, A., Turner, N., Quercetin and chlorogenic acid affect butyrate excretion, NF-κB activity, and cell proliferation in DSS treated rats. FASEB J., 26, 2012 263.266–263.266.
203. Turner, N., Paulhill, K., Warren, C., Davidson, L., Chapkin, R., Lupton, J., Carroll, R., Wang, N., Quercetin suppresses early colon carcinogenesis partly through inhibition of inflammatory mediators. II International Symposium on Human Health Effects of Fruits and Vegetables: FAVHEALTH 2007 8412007, 2017, 237–242.
204. Warren, C.A., Paulhill, K.J., Davidson, L.A., Lupton, J.R., Taddeo, S.S., Hong, M.Y., Carroll, R.J., Chapkin, R.S., Turner, N.D., Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J. Nutr. 139 (2009), 101–105.
205. Zhang, X.A., Zhang, S., Yin, Q., Zhang, J., Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacogn. Mag. 11 (2015), 404–409.
206. Refolo, M.G., D'Alessandro, R., Malerba, N., Laezza, C., Bifulco, M., Messa, C., Caruso, M.G., Notarnicola, M., Tutino, V., Anti proliferative and pro apoptotic effects of flavonoid quercetin are mediated by CB1 receptor in human colon cancer cell lines. J. Cell. Physiol. 230 (2015), 2973–2980.
207. Han, M., Song, Y., Zhang, X., Quercetin suppresses the migration and invasion in human colon cancer Caco-2cells through regulating Toll-like receptor 4/nuclear factor-kappa B pathway. Pharmacogn. Mag. 12 (2016), S237–244.
208. Dihal, A.A., de Boer, V.C., van der Woude, H., Tilburgs, C., Bruijntjes, J.P., Alink, G.M., Rietjens, I.M., Woutersen, R.A., Stierum, R.H., Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats. J. Nutr. 136 (2006), 2862–2867.
209. Peters, R., Lock, R.H., Laxative effect of sorbitol. Br. Med. J. 2 (1958), 677–678.
210. Lu, X., Li, C., Wang, Y.K., Jiang, K., Gai, X.D., Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction. Oncol. Lett. 7 (2014), 1992–1996.
211. Yang, Y., Gallaher, D.D., Effect of dried plums on colon cancer risk factors in rats. Nutr. Cancer 53 (2005), 117–125.
212. Glinghammar, B., Inoue, H., Rafter, J.J., Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis 23 (2002), 839–845.
213. Baijal, P.K., Clow, E.P., Fitzpatrick, D.W., Bird, R.P., Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype. Can. J. Physiol. Pharmacol. 76 (1998), 1095–1102.
214. Selmin, O.I., Fang, C., Lyon, A.M., Doetschman, T.C., Thompson, P.A., Martinez, J.D., Smith, J.W., Lance, P.M., Romagnolo, D.F., Inactivation of adenomatous polyposis coli reduces bile acid/Farnesoid X receptor expression through Fxr gene CpG methylation in mouse colon tumors and human colon cancer cells. J. Nutr. 146 (2016), 236–242.
215. Liu, R.H., Whole grain phytochemicals and health. J. Cereal Sci. 46 (2007), 207–219.
216. Dykes, L., Rooney, L.W., Sorghum and millet phenols and antioxidants. J. Cereal Sci. 44 (2006), 236–251.
217. Awika, J.M., McDonough, C.M., Rooney, L.W., Decorticating sorghum to concentrate healthy phytochemicals. J. Agric. Food Chem. 53 (2005), 6230–6234.
218. Ritchie, L., Taddeo, S., Weeks, B., Carroll, R., Dykes, L., Rooney, L., Turner, N., Impact of novel sorghum bran diets on DSS-induced colitis. Nutrients, 9, 2017, 330.
219. Ritchie, L.E., Sturino, J.M., Azcarate-Peril, M.A., Turner, N.D., Novel sorghum brans containing bioactive compounds alter colon microbiota in response to a DSS-induced chronic inflammatory state. FASEB J., 27, 2013 247.242.
220. Walisser, J.A., Glover, E., Pande, K., Liss, A.L., Bradfield, C.A., Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 17858–17863.
221. Kawajiri, K., Kobayashi, Y., Ohtake, F., Ikuta, T., Matsushima, Y., Mimura, J., Pettersson, S., Pollenz, R.S., Sakaki, T., Hirokawa, T., Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc. Natl. Acad. Sci. 106 (2009), 13481–13486.
222. Benson, J.M., Shepherd, D.M., Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol. Sci. 120 (2011), 68–78.
223. Furumatsu, K., Nishiumi, S., Kawano, Y., Ooi, M., Yoshie, T., Shiomi, Y., Kutsumi, H., Ashida, H., Fujii-Kuriyama, Y., Azuma, T., Yoshida, M., A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig. Dis. Sci. 56 (2011), 2532–2544.
224. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147 (2011), 629–640.
225. Wincent, E., Bengtsson, J., Mohammadi Bardbori, A., Alsberg, T., Luecke, S., Rannug, U., Rannug, A., Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 4479–4484.
226. Mohammadi-Bardbori, A., Bengtsson, J., Rannug, U., Rannug, A., Wincent, E., Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR). Chem. Res. Toxicol. 25 (2012), 1878–1884.
227. DiNatale, B.C., Murray, I.A., Schroeder, J.C., Flaveny, C.A., Lahoti, T.S., Laurenzana, E.M., Omiecinski, C.J., Perdew, G.H., Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci. 115 (2010), 89–97.
228. Jin, U.H., Lee, S.O., Sridharan, G., Lee, K., Davidson, L.A., Jayaraman, A., Chapkin, R.S., Alaniz, R., Safe, S., Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol. Pharmacol. 85 (2014), 777–788.
229. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
230. Diaz-Diaz, C.J., Ronnekleiv-Kelly, S.M., Nukaya, M., Geiger, P.G., Balbo, S., Dator, R., Megna, B.W., Carney, P.R., Bradfield, C.A., Kennedy, G.D., The aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse. Ann. Surg. 264 (2016), 429–436.
231. Reid, G., Sanders, M.E., Gaskins, H.R., Gibson, G.R., Mercenier, A., Rastall, R., Roberfroid, M., Rowland, I., Cherbut, C., Klaenhammer, T.R., New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37 (2003), 105–118.
232. Delia, P., Sansotta, G., Donato, V., Messina, G., Frosina, P., Pergolizzi, S., De Renzis, C., Famularo, G., Prevention of radiation-induced diarrhea with the use of VSL# 3, a new high-potency probiotic preparation. Am. J. Gastroenterol., 97, 2002, 2150.
233. Osterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., Joensuu, H., Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br. J. Cancer 97 (2007), 1028–1034.
234. Giralt, J., Regadera, J.P., Verges, R., Romero, J., de la Fuente, I., Biete, A., Villoria, J., Cobo, J.M., Guarner, F., Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int. J. Radiat. Oncol. Biol. Phys. 71 (2008), 1213–1219.
235. Orrhage, K., Sillerstrom, E., Gustafsson, J.A., Nord, C.E., Rafter, J., Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311 (1994), 239–248.
236. Rowland, I.R., Grasso, P., Degradation of N-nitrosamines by intestinal bacteria. Appl. Microbiol. 29 (1975), 7–12.
237. Goldin, B., Gorbach, S.L., Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine. Cancer 40 (1977), 2421–2426.
238. Reddy, B.S., Rivenson, A., Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res. 53 (1993), 3914–3918.
239. Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
240. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
241. Le Leu, R.K., Hu, Y., Brown, I.L., Woodman, R.J., Young, G.P., Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31 (2010), 246–251.
242. Challa, A., Rao, D.R., Chawan, C.B., Shackelford, L., Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18 (1997), 517–521.
243. Bolognani, F., Rumney, C.J., Pool-Zobel, B.L., Rowland, I.R., Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 40 (2001), 293–300.
244. Rowland, I.R., Rumney, C.J., Coutts, J.T., Lievense, L.C., Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19 (1998), 281–285.
245. Kulkarni, N., Reddy, B.S., Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Exp. Biol. Med. 207 (1994), 278–283.
246. McIntosh, G.H., Royle, P.J., Playne, M.J., A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr. Cancer 35 (1999), 153–159.
247. Yamazaki, K., Tsunoda, A., Sibusawa, M., Tsunoda, Y., Kusano, M., Fukuchi, K., Yamanaka, M., Kushima, M., Nomoto, K., Morotomi, M., The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol. Rep. 7 (2000), 977–982.
248. Gamallat, Y., Meyiah, A., Kuugbee, E.D., Hago, A.M., Chiwala, G., Awadasseid, A., Bamba, D., Zhang, X., Shang, X., Luo, F., Xin, Y., Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed. Pharmacother. 83 (2016), 536–541.
249. Silva, M.F., Sivieri, K., Rossi, E.A., Effects of a probiotic soy product and physical exercise on formation of pre-neoplastic lesions in rat colons in a short-term model of carcinogenic. J. Int. Soc. Sports Nutr., 6, 2009, 17.
250. Li, W., Li, C.B., Lack of inhibitory effects of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rats. World J. Gastroenterol. 9 (2003), 2469–2473.
251. Raz, I., Gollop, N., Polak-Charcon, S., Schwartz, B., Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Br. J. Nutr. 97 (2007), 725–734.
252. Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., Jenkins, D.J., Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40 (2006), 235–243.
253. Azcarate-Peril, M.A., Sikes, M., Bruno-Barcena, J.M., The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?. Am. J. Physiol. 301 (2011), G401–424.
254. Azcarate-Peril, M.A., Altermann, E., Goh, Y.J., Tallon, R., Sanozky-Dawes, R.B., Pfeiler, E.A., O'Flaherty, S., Buck, B.L., Dobson, A., Duong, T., et al. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl. Environ. Microbiol. 74 (2008), 4610–4625.
255. Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., Kohgo, Y., Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat. Commun., 7, 2016, 12365.
256. Kemp, M.Q., Jeffy, B.D., Romagnolo, D.F., Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J. Nutr. 133 (2003), 3670–3677.
257. Dubey, V., Gosh, A.R., Bishayee, K., Khuda-Bukhsh, A.R., Appraisal of the anti-cancer potential of probiotic Pediococcus pentosaceus GS4 against colon cancer: in vitro and in vivo approaches. J. Funct. Foods 23 (2016), 66–79.
258. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
259. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Rolph, M.S., Mackay, F., Artis, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
260. O'toole, P.W., Flemer, B., Studying the microbiome:omics made accessible. Seminars in Liver Disease, 2016, Thieme Medical Publishers, 306–311.
261. Weinstock, G.M., Genomic approaches to studying the human microbiota. Nature 489 (2012), 250–256.
262. Kuczynski, J., Stombaugh, J., Walters, W.A., González, A., Caporaso, J.G., Knight, R., Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Current Protocols in Microbiology, 2005, John Wiley & Sons, Inc.
263. Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31 (2013), 814–821.
264. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000), 27–30.
265. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000), 25–29.
266. Franzosa, E.A., Morgan, X.C., Segata, N., Waldron, L., Reyes, J., Earl, A.M., Giannoukos, G., Boylan, M.R., Ciulla, D., Gevers, D., et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E2329–2338.
267. Sridharan, G.V., Choi, K., Klemashevich, C., Wu, C., Prabakaran, D., Pan, L.B., Steinmeyer, S., Mueller, C., Yousofshahi, M., Alaniz, R.C., et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat. Commun., 5, 2014, 5492.
268. Gelman, S.J., Patti, G.J., Profiling cancer metabolism at the ‘omic’ level: a last resort or the next frontier?. Cancer Metab., 4, 2016, 2.
269. Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA 64 (2014), 104–117.
270. Boursi, B., Arber, N., Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr. Pharm. Des. 13 (2007), 2274–2282.
271. Phillips, C.M., Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 5 (2013), 32–57.
272. Ordovas, J.M., Corella, D., Nutritional genomics. Annu. Rev. Genom. Hum. Genet. 5 (2004), 71–118.
273. Stover, P.J., Nutritional genomics. Physiol. Genom. 16 (2004), 161–165.
274. Elliott, R., Ong, T.J., Nutritional genomics. BMJ Br. Med. J., 324, 2002, 1438.
275. Trujillo, E., Davis, C., Milner, J., Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J. Am. Dietetic Assoc. 106 (2006), 403–413.
276. Liang, Q., Chiu, J., Chen, Y., Huang, Y., Higashimori, A., Fang, J., Brim, H., Ashktorab, H., Ng, S.C., Ng, S.S.M., et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin. Cancer Res. 23 (2017), 2061–2070.
277. Venugopalan, V., Shriner, K.A., Wong-Beringer, A., Regulatory oversight and safety of probiotic use. Emerg. Infect. Dis. 16 (2010), 1661–1665.
278. Breton, J., Tennoune, N., Lucas, N., Francois, M., Legrand, R., Jacquemot, J., Goichon, A., Guérin, C., Peltier, J., Pestel-Caron, M., Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab. 23 (2016), 324–334.
279. Khan, M.J., Gerasimidis, K., Edwards, C.A., Shaikh, M.G., Role of gut microbiota in the aetiology of obesity: proposed mechanisms and review of the literature. J. Obes., 2016, 2016.
280. Fuentes, C.T., Schellekens, H., Hoevenaars, N., Ross, P., Roy, B., Stanton, C., Dinan, T.G., Cryan, J.F., Identification of novel probiotics to modify appetite and satiety directly targeting the ghrelin receptor. FASEB J., 30, 2016 717.712–717.712.
281. Burcelin, R., When gut fermentation controls satiety: a PYY story. Mol. Metab. 6 (2017), 10–11.
282. Fetissov, S.O., Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat. Rev. Endocrinol. 13 (2017), 11–25.